Topical anti-inflammatory drug therapy

Details Topical anti-inflammatory drug therapy Topical anti-inflammatory drug therapy

1979-08-06

1981-08-04

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

424274, 424317, 424327, A61K 3115, A61K 3119, A61K 3140, A61K 3156

Patent

active

042822165

ABSTRACT:
A pharmaceutical composition for topical treatment of cutaneous disorders or disruptions characterized by skin inflammation or hyperproliferative epidermal activity comprises the combination of a topically active anti-inflammatory corticosteroid and a non-steroidal anti-inflammatory agent which is an inhibitor of prostaglandin synthetase selected from the group consisting of the hydratropic acid derivatives; acetylsalicylic acid; the pyrazolone derivatives; the fenamic acid derivatives; the aroyl-substituted pyrroles and the substituted arylacetohydroxamic acids in a pharmaceutically acceptable topical vehicle. Treatment of above cutaneous disorders may also be effected by concurrent therapy using separate applications of corticosteroid and non-steroid.

REFERENCES:
Merck Index, pp. 1224 and 1233.

Affiliated with

Also associated with

Rating

Topical anti-inflammatory drug therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Topical anti-inflammatory drug therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical anti-inflammatory drug therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-240155